Depsides and depsidones

Medchemexpress LLC Fotagliptin benzoate | 1403496-40-1 | 99.2% | 464.49 g/mol | C24H25FN6O3 | 10MM 1ML

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Fotagliptin benzoate is a dipeptidyl peptidase-4 (DPP-4) inhibitor supplied for preclinical research. It is available as a solid or as a ready-to-use 10 mM solution in DMSO (1 mL) for in vitro assays and compound screening.

• Potent DPP-4 inhibitor (IC50 = 2.27 nM).
• Available as 10 mM solution in DMSO (1 mL) or as a solid for stock preparation.
• Molecular formula C24H25FN6O3; molecular weight 464.49 g/mol.
• High reported purity for research use.
• Storage: solid at 4°C; in solvent -80°C up to 6 months or -20°C up to 1 month.
• Suitable for in vitro DPP-4 inhibition assays and preclinical studies.

Medchemexpress LLC Alogliptin benzoate | 850649-62-6 | 100.0% | 461.51 g·mol⁻¹ | C25H27N5O4 | 10 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Alogliptin benzoate is the benzoate salt of alogliptin, a potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor used for biochemical and preclinical research related to metabolic and cardiovascular disease. Supplied as a high-purity research reagent, it is intended for laboratory use only and not for human or clinical use.

• Potent DPP-4 inhibitor with reported IC50 <10 nM.
• High purity (HPLC) - 99.96%.
• Molecular formula C25H27N5O4; molecular weight 461.51 g·mol⁻¹.
• Available in small package sizes suitable for analytical work.
• Store at 4°C sealed and away from moisture; in solution store at -80°C (6 months) or -20°C (1 month).
• For research use only; not intended for human use.

Medchemexpress LLC Fotagliptin benzoate | 1403496-40-1 | 99.2% | 464.49 g/mol | C24H25FN6O3 | 10MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Fotagliptin benzoate is the benzoate salt form of fotagliptin, a potent dipeptidyl peptidase-4 (DPP-4) inhibitor used in preclinical research for Type 2 diabetes. The compound is supplied in small research quantities and is characterized for in vitro and in vivo formulations, with documented solubility and storage recommendations to support pharmacology studies.

• CAS 1403496-40-1.
• Molecular formula C24H25FN6O3 and molecular weight 464.49 g/mol.
• Reported DPP-4 inhibitory activity (IC50 ≈ 22.7 nM).
• High solubility in DMSO (100 mg/mL) and reported in vivo formulations with solubility ≥ 2.5 mg/mL.
• Storage: 4°C sealed; in solvent -80°C (6 months) or -20°C (1 month).
• Available in small pack sizes for research use (examples: 1 mg, 5 mg, 10 mg).